Bellevue Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,700	Closed	-$330K	–	170
2024 Q2	$330K	Hold	15,700	–	–	0.01%	136
2024 Q1	$500K	Buy	+15,700	New	+$500K	0.01%	130
2023 Q3	–	Sell	-45,000	Closed	-$813K	–	159
2023 Q2	$813K	Buy	+45,000	New	+$813K	0.01%	134